NMDA Receptor Antagonist and Use Thereof
US-2024254095-A1 · Aug 1, 2024 · US
Heterocyclic modulators of HIF activity for treatment of disease
US9018380B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9018380-B2 |
| Application number | US-201313974258-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 23, 2013 |
| Priority date | Aug 24, 2012 |
| Publication date | Apr 28, 2015 |
| Grant date | Apr 28, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of structural Formula III: or a salt thereof, wherein: X 2 and X 4 are N and X 5 is O; X 4 and X 5 are N and X 2 is O; X 2 and X 5 are N and X 4 is O; X 2 is CH, X 4 is N, and X 5 is O; or X 2 is CH, X 4 is O, and X 5 is N; Z 2 is selected from the group consisting of N and CR 14 ; R 1 is selected from the group co…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- C07D413/04Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9018380B2 cover?
- The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
- Who is the assignee on this patent?
- Inst Applied Cancer Science The University Of Texas Md Anderson Cancer Ct, Univ Texas
- What technology area does this patent fall under?
- Primary CPC classification C07D413/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).